Strides, listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR), is a global  pharmaceutical  company  headquartered  in  Bangalore,  India.    The  Company  mainly  operates  in  the  regulated markets and has an “in Africa for Africa” strategy along with an institutional business to service  donor‐funded  markets.  The  Company’s  global  manufacturing  sites  are  located  in  India‐  Bangalore  (two  sites),  Pondicherry,  and  Chennai,  Singapore,  Italy‐  Milan,  Kenya‐  Nairobi  and  United  States‐Florida.  The  Company  focusses on “difficult  to manufacture” products  that are  sold in over  100 countries.